Showing results (131-140 of 146) with videos related to
Sort By:
Pageof 15
Epilepsia|June 1, 1996
Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizuresE Ben-Menachem, O Henriksen, M Dam, et al.The Journal of Endocrinology|December 1, 1982
Incidence, growth and oestradiol-receptor levels of 7, 12-dimethylbenz (alpha) anthracene-induced mammary tumours in rats: effects of neonatal sex steroids and oestradiol implantsG Verhoeven, G Vandoren, W Heyns, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2017
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trialE Lesaffre, M J Edelman, N H Hanna, et al.JAMA|October 4, 1995
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)W Hacke, M Kaste, C Fieschi, et al.European Journal of Nuclear Medicine|December 1, 1993
A new quantitative method for the analysis of cardiac perfusion tomography (SPET): validation in post-infarct patients treated with thrombolytic therapyL Mortelmans, J Nuyts, I Scheys, et al.Journal of the American College of Cardiology|August 1, 1993
Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapyF Van de Werf, L Janssens, T Brzostek, et al.Stroke|November 5, 1999
Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohortM Fiorelli, S Bastianello, R von Kummer, et al.American Heart Journal|June 1, 1990
Evaluation of the effect of thrombolytic treatment on infarct size and left ventricular function by enzymatic, scintigraphic, and angiographic methods. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen ActivatorL Mortelmans, J Vanhaecke, E Lesaffre, et al.Neurology|January 29, 2003
A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsyF G Gilliam, F Veloso, M A M Bomhof, et al.Controlled Clinical Trials|October 6, 2000
Fraud in medical research: an international survey of biostatisticians. ISCB Subcommittee on FraudJ Ranstam, M Buyse, S L George, et al.Pageof 15